Could this Tech Stock really climb 257.14% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Will FDA News Lift This Stock?]( [Click Here Now.]( --------------------------------------------------------------- March 29, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [FDA news shines light on this little-known clinical-stage Pharma]( Reader, This little-known clinical-stage pharma company recently received a favorable decision from the FDA and it's shining a light on its potential for significant growth. Could we be looking at 1,788% in upside potential? Free report reveals the name, ticker symbol, and 14 reasons to immediately start your research on this company. Don’t miss out on this one... [Click Here For Free Report]( --------------------------------------------------------------- [Stolt-Nielsen]( Symbol: [SOIEF]( Recent Price: $31.10 Average Analyst Price Target: $45.98 (48.46%) Market Cap: $1.67B Last Year's EPS: $0.09 Consensus EPS Forecast: $1.76 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Anders Karlsen, analyst at Kepler Capital , reiterates coverage on [Stolt-Nielsen (SOIEF)]( in the Industrial Goods sector with a Buy rating and a price target of $46.17 (4 days ago). [TipRanks.com]( also reports that [Stolt-Nielsen]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $45.98. The target pricing ranges from a high forecast of $45.98 down to a low forecast of $45.98. [Stolt-Nielsen (SOIEF)](’s last closing price was $31.10 which would put the average price target at 48.46% upside. Here are 3rd party ratings for [SOIEF](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Biden To Unleash "Choke Point" Operation On America?]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Altus Power]( Symbol: [AMPS]( Recent Price: $5.22 Average Analyst Price Target: $12.33 (136.21%) Market Cap: $867.62M Last Year's EPS: $0.06 Consensus EPS Forecast: $0.01 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Jon Windham, analyst at UBS, reiterates coverage on [Altus Power (AMPS)]( in the Utilities sector with a Buy rating and a price target of $10.00 (19 hours ago). [TipRanks.com]( also reports that [Altus Power]( currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.33. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $10.00. [Altus Power (AMPS)](’s last closing price was $5.22 which would put the average price target at 136.21% upside. Here are 3rd party ratings for [AMPS](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 32% (171 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Bassett Furniture]( Symbol: [BSET]( Recent Price: $18.90 Average Analyst Price Target: $32.00 (69.31%) Market Cap: $167.32M Last Year's EPS: $0.44 Consensus EPS Forecast: $0.24 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Joe Gomes, analyst at Noble Financial, reiterates coverage on [Bassett Furniture (BSET)]( in the Consumer Goods sector with a Buy rating and a price target of $32.00 (2 months ago). [TipRanks.com]( also reports that [Bassett Furniture]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $32.00. The target pricing ranges from a high forecast of $32.00 down to a low forecast of $32.00. [Bassett Furniture (BSET)](’s last closing price was $18.90 which would put the average price target at 69.31% upside. Here are 3rd party ratings for [BSET](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Sell, Bottom 20% (200 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Biden's Puppet Master... REVEALED]( you ever suspected that Joe Biden’s not really running America… And that there’s someone else pulling the strings… You’re right! [Click here to see his identity… and discover how he’s about to destroy your way of life]( --------------------------------------------------------------- [CD Projekt SA]( Symbol: [OTGLF]( Recent Price: $24.52 Average Analyst Price Target: $25.78 (6.10%) Market Cap: $2.65B Last Year's EPS: $0.2 Consensus EPS Forecast: $0.25 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: George Brown, analyst at Deutsche Bank, reiterates coverage on [CD Projekt SA (OTGLF)]( in the Technology sector with a Hold rating and a price target of $26.54 (1 day ago). [TipRanks.com]( also reports that [CD Projekt SA]( currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $25.78. The target pricing ranges from a high forecast of $35.80 down to a low forecast of $17.67. [CD Projekt SA (OTGLF)](’s last closing price was $24.52 which would put the average price target at 6.10% upside. Here are 3rd party ratings for [OTGLF](: - TipRanks.com: Moderate Sell - TradingView.com: Strong Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [K92 Mining]( Symbol: [KNTNF]( Recent Price: $5.98 Average Analyst Price Target: $7.97 (33.35%) Market Cap: $1.36B Last Year's EPS: $0.05 Consensus EPS Forecast: $0.09 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Wayne Lam, analyst at RBC Capital, reiterates coverage on [K92 Mining (KNTNF)]( in the Basic Materials sector with a Hold rating and a price target of $6.96 (3 weeks ago). [TipRanks.com]( also reports that [K92 Mining]( currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.97. The target pricing ranges from a high forecast of $10.26 down to a low forecast of $6.78. [K92 Mining (KNTNF)](’s last closing price was $5.98 which would put the average price target at 33.35% upside. Here are 3rd party ratings for [KNTNF](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Dividend Stock to Leave for Your Grandchildren]( you tired of your so-called "safe" income stocks slashing dividends while the share prices fall? There is a better way. I just revealed my safest most reliable and [most consistent dividend stock]( - and it pays a sky high yield with dividends paid EVERY month. This company has also increased its monthly dividend twice a year every year for the past 8 years. [Tap here to reveal the name of this stock for free.]( --------------------------------------------------------------- [MarketWise]( Symbol: [MKTW]( Recent Price: $1.68 Average Analyst Price Target: $6.00 (257.14%) Market Cap: $539.44M Last Year's EPS: $0.12 Consensus EPS Forecast: $0.06 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Devin Ryan, analyst at JMP Securities, reiterates coverage on [MarketWise (MKTW)]( in the Technology sector with a Buy rating and a price target of $6.00 (2 weeks ago). [TipRanks.com]( also reports that [MarketWise]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00. The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. [MarketWise (MKTW)](’s last closing price was $1.68 which would put the average price target at 257.14% upside. Here are 3rd party ratings for [MKTW](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 40% (101 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Medios AG]( Symbol: [MEDOF]( Recent Price: $50 Average Analyst Price Target: $32.28 (-35.10%) Market Cap: $520.07M Last Year's EPS: -$0.12 Consensus EPS Forecast: $0.29 Expected Earnings Date: Mar 30 2023 Recent Analyst Action: Michael Kuhn, analyst at Deutsche Bank, reiterates coverage on [Medios AG (MEDOF)]( in the Healthcare sector with a Buy rating and a price target of $27.04 (3 weeks ago). [TipRanks.com]( also reports that [Medios AG]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $32.28. The target pricing ranges from a high forecast of $37.66 down to a low forecast of $26.90. [Medios AG (MEDOF)](’s last closing price was $50 which would put the average price target at -35.10% upside. Here are 3rd party ratings for [MEDOF](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Pharma Stock: 1,788% Upside?]( a Little-Known Pharma Stock with an Innovative Pipeline - [Click Here for Symbol.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software